Pfizer Inc. (NYSE:PFE) is among the 12 Best Ethical Companies to Invest in 2025. On July 24, 2025, Pfizer Inc. (NYSE:PFE) ...

Pfizer Inc. (NYSE: PFE) announced today the completion of a global, ex-China, licensing agreement with 3SBio, Inc. (01530.HK) ...

As part of the agreement, which was signed in May 2025, 3SBio will receive $1.25bn, along with a $100m equity investment from ...

Pfizer agreed to an upfront payment of US$1.25 billion, US$150 million for mainland rights and a US$100 million equity ...

Moderna has scrapped plans to build an mRNA plant in Japan. Otsuka and Lundbeck's proposal for Rexulti as part of a PTSD ...

Pfizer inks $1.25 billion deal with 3SBio for cancer drug ...

Northeastern Chinese company 3SBio to receive $1.25B, in addition to $100M equity investment, $150M for exclusive rights in ...

New capital, maturing pipelines, and a more global R&D mindset are pushing valuations higher, even as competition tightens.

Pfizer has entered into an exclusive global, ex-China, licensing agreement with 3SBio a Chinese biopharmaceutical company, listed on the Hong Kong Stock Exchange (HKEX), according to a May 19 company ...

3SBio said the drug had been cleared by the U.S. Food and Drug Administration for its investigational new drug application. China’s 3SBio surges 36% on Pfizer licensing deal View all comments (0) 0 ...

Investing.com-- Shares of 3SBio Inc (HK: 1530) skyrocketed in Hong Kong trade on Tuesday after the company licensed an experimental cancer treatment to U.S. drugmaker Pfizer Inc (NYSE: PFE), with the ...